Seeing Is Believing
BLTE is currently covered by 5 analysts with an average price target of $204.4. This is a potential upside of $49 (28.96%) from yesterday's end of day stock price of $158.5.
Belite Bio ADR's activity chart (see below) currently has 33 price targets and 46 ratings on display. The stock rating distribution of BLTE is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 58.69% with an average time for these price targets to be met of 146.46 days.
Highest price target for BLTE is $266, Lowest price target is $140, average price target is $204.4.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 15-Jun-2026. First documented stock forecast 01-Jul-2022.
Currently out of the existing stock ratings of BLTE, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Aug-2022
$200
$41.39 (26.10%)
$200
Buy Since 26-May-2026
$215
$56.39 (35.55%)
$194
Buy Since 06-Jan-2026
$201
$42.39 (26.73%)
$191
Buy Since 03-Mar-2026
$266
$107.39 (67.71%)
$154
Buy Since 14-Dec-2023
$140
$-18.61 (-11.73%)
$110
What is BLTE (Belite Bio ADR) average time for price targets to be met?
Which analyst has the current highest performing score on BLTE (Belite Bio ADR) with a proven track record?
Which analyst has the most public recommendations on BLTE (Belite Bio ADR)?
Which analyst is the currently most bullish on BLTE (Belite Bio ADR)?
Which analyst is the currently most reserved on BLTE (Belite Bio ADR)?